Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss.

Kline EM, Butkovich LM, Bradner JM, Chang J, Gelbard H, Goodfellow V, Caudle WM, Tansey MG.

Exp Neurol. 2019 Aug;318:157-164. doi: 10.1016/j.expneurol.2019.05.002. Epub 2019 May 8.

PMID:
31077715
2.

Reward-Related Expectations Trigger Dendritic Spine Plasticity in the Mouse Ventrolateral Orbitofrontal Cortex.

Whyte AJ, Kietzman HW, Swanson AM, Butkovich LM, Barbee BR, Bassell GJ, Gross C, Gourley SL.

J Neurosci. 2019 Jun 5;39(23):4595-4605. doi: 10.1523/JNEUROSCI.2031-18.2019. Epub 2019 Apr 2.

PMID:
30940719
3.

α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis.

Butkovich LM, Houser MC, Tansey MG.

Front Neurosci. 2018 Sep 11;12:626. doi: 10.3389/fnins.2018.00626. eCollection 2018. Review.

4.

LRRK2 levels in immune cells are increased in Parkinson's disease.

Cook DA, Kannarkat GT, Cintron AF, Butkovich LM, Fraser KB, Chang J, Grigoryan N, Factor SA, West AB, Boss JM, Tansey MG.

NPJ Parkinsons Dis. 2017 Mar 28;3:11. doi: 10.1038/s41531-017-0010-8. eCollection 2017.

5.

Adolescent-onset GABAA α1 silencing regulates reward-related decision making.

Butkovich LM, DePoy LM, Allen AG, Shapiro LP, Swanson AM, Gourley SL.

Eur J Neurosci. 2015 Aug;42(4):2114-2121. doi: 10.1111/ejn.12995. Epub 2015 Aug 4.

Supplemental Content

Loading ...
Support Center